After leading diabetes and obesity drug discovery for 10 years at Merck, Moller moved to Lilly in 2006 because of the opportunity to broaden his therapeutic area experience to include ...

With the discovery of insulin at the University of Toronto in the early 1920’s, followed by the establishment of commercial production, diabetes was no longer a ... Grinding pancreases for insulin at ...

Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus ... Jardiance is propping up Boehringer’s balance sheets, generating annual sales of more than ...

The principal liabilities of the two marketed TZDs, rosiglitazone (Avandia; GlaxoSmithKline) and pioglitazone (Actos; Takeda/Eli Lilly ... Diabetes Association (ADA). National Diabetes Fact Sheet ...